Colgate-Palmolive outperforms its peers in terms of profitability, with a strong gross profit margin and a high return on ...

We recently published a list of 15 Dividend Zombies to Invest in. In this article, we are going to take a look at where ...

StockNews.com lowered shares of Colgate-Palmolive (NYSE:CL – Free Report) from a buy rating to a hold rating in a research ...

Diamond Hill Capital, an investment management company, released its “Large Cap Strategy” fourth-quarter 2024 investor letter ...

Colgate-Palmolive's strong Latin American demand faces US dollar challenges. Learn why CL stock remains a good buy with ...

We recently published a list of 15 Best Defensive Stocks Amid Market Volatility In this article, we are going to take a look ...

Getting dozens of ad agency partners around the world to work together is like herding cats – but Colgate-Palmolive was able ...

We recently published a list of the 12 Best Household Stocks to Buy According to Hedge Funds. In this article, we are going ...

Analysts expect a meagre 1.5% revenue growth and 1% volume growth for Colgate Palmolive in the fourth quarter.

In the past two months, shares of Colgate Palmolive (India), the market leader in oral care in the country, has ...

Barclays analyst Lauren Lieberman maintained a Hold rating on Colgate-Palmolive (CL – Research Report) today and set a price target of $89.00.

Barclays raised the firm’s price target on Colgate-Palmolive (CL) to $89 from $83 and keeps an Equal Weight rating on the shares. Ahead of Q1 ...